Amotas LB 625 Tablet is a pharmaceutical product manufactured by GrowSure Healthcare. It contains Amoxycillin, Potassium Clavulanate and Lactic Acid Bacillus. This product is manufactured under quality standards and is offered for hospitals, clinics, distributors and PCD pharma partners.
Amotas LB 625 combines Amoxycillin, a powerful antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor that prevents bacterial resistance. Added Lactic Acid Bacillus (probiotic) supports gut health, preventing antibiotic-associated diarrhea.
| Composition | Amoxycillin Trihydrate IP eq to Amoxycillin 500 mg + Potassium Clavulanate Diluted IP eq to Clavulanic Acid 125 mg + Lactic Acid Bacillus 60 Million Spores |
| Dosage Form | Tablets |
| Packaging Size | 10 x 6 Tablets (Strip) |
| Indications | Upper & lower respiratory tract infections, urinary tract infections, skin & soft tissue infections, and dental infections. |
| Maximum Retail Price (MRP) | ₹260.00 (incl. of all taxes) |